Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

ClinicalTrials.gov ID: NCT03921541

Public ClinicalTrials.gov record NCT03921541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

CAEB1102-300A is a multi-center randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of pegzilarginase in patients with ARG1-D. This study will consist of a screening period; a randomized, double-blind treatment period; a long-term extension; and a follow up visit for final safety assessments.

Study identification

NCT ID
NCT03921541
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Immedica Pharma AB
Industry
Enrollment
32 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2019 (Actual)
Primary completion
Feb 1, 2023 (Actual)
Completion
Feb 1, 2023 (Actual)
Last update posted
Aug 21, 2026

2019 – 2023

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Harvey Pediatrics Rogers Arkansas 72758 —
Children's Hospital of Orange County Orange California 92868 —
Stanford University School of Medicine Stanford California 94305 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of Florida College of Medicine Gainesville Florida 32610 —
Emory University Atlanta Georgia 30322 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Cohen Children's Medical Center (Northwell Health) Queens New York 11040 —
Duke University Medical Center Durham North Carolina 27710 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15224 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
UT Southwestern Medical Center Dallas Texas 75390 —
University of Texas Health Science Center Medical School at Houston Houston Texas 77030 —
University of Utah Hospitals & Clinics Salt Lake City Utah 84108 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03921541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03921541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →